Liver Embolization Approaches for Tumor Management

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorIRCCS San Raffaele

About this trial

The goal of this evaluate short, medium and long term outcome of the different embolization techniques in patients with primary and secondary hepatic tumors. The main aim is to evaluate progression free survival following embolization in this study population or evaluate residual hepatic volume in cases in which these techniques are used to induce liver regeneration. This study is an observational registry - all patients will follow their normal therapeutic and treatment scheme as per clinical practice, without any additional intervention.

Eligibility criteria

Qualifiers

≥ 18 yoa

patients with patients with primary or secondary liver disease not amenable for surgery or ablation

patients with primary or secondary liver tumors candidates for major surgery prior to induction of hypertrophy

able and willing to sign informed consent

Disqualifiers

pregnant women

patients with uncorrectable coagulopathy

diffuse extrahepatic disease

for lobar TACE and TARE - presence of bilodigestive shunt

Trial design

Treatments tested in this trial

  • Embolization

Treatment groups

No treatment groups listed

Sponsors and collaborators